You are here

Article info

Article menu
Download PDFPDF
Scientific Abstracts
Poster Presentations
Posters
Basic science in paediatric rheumatology
THU0295 Isotype characterization of anti-infliximab antibodies in pediatric patients with rheumatic diseases treated with infliximab

Authors

  • M. Kosmač 1Department for Production of Diagnostic Reagents and Research, Blood Transfusion Centre of Slovenia 2Faculty of Chemistry and Chemical Technology, University of Ljubljana 3Department of Allergology, Rheumatology and Clinical Immunology, University Children’s Hospital, University Medical Centre, Ljubljana, Slovenia PubMed articlesGoogle scholar articles
  • N. Toplak 3Department of Allergology, Rheumatology and Clinical Immunology, University Children’s Hospital, University Medical Centre, Ljubljana, Slovenia PubMed articlesGoogle scholar articles
  • G. Simonini 4Rheumatology Unit, Anna Meyer Children’s Hospital and University of Florence, Florence, Italy PubMed articlesGoogle scholar articles
  • R. Cimaz 4Rheumatology Unit, Anna Meyer Children’s Hospital and University of Florence, Florence, Italy PubMed articlesGoogle scholar articles
  • V. Čurin Šerbec 1Department for Production of Diagnostic Reagents and Research, Blood Transfusion Centre of Slovenia 2Faculty of Chemistry and Chemical Technology, University of Ljubljana PubMed articlesGoogle scholar articles
  • T. Avčin 3Department of Allergology, Rheumatology and Clinical Immunology, University Children’s Hospital, University Medical Centre, Ljubljana, Slovenia PubMed articlesGoogle scholar articles

Citation

Kosmač M, Toplak N, Simonini G, et al
THU0295 Isotype characterization of anti-infliximab antibodies in pediatric patients with rheumatic diseases treated with infliximab
Annals of the Rheumatic Diseases 2013;71:255.

Publication history

  • First published January 23, 2014.
Online issue publication 
April 13, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2013, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions